Advertisement

New PSA Screening Guideline from the American Urological Association

June 6, 2013

New PSA Screening Guideline from the American Urological Association

  1. Allan S. Brett, MDAU031

The target range for “routine” prostate-specific antigen screening has been narrowed to ages 55 to 69.

  1. Allan S. Brett, MDAU031

The American Urological Association (AUA) has published a new guideline on prostate-specific antigen (PSA) screening. The guideline has five summary recommendations:

  • No screening for men younger than 40.

  • No “routine” screening for men aged 40 to 54 and at average risk; for those in this age group who are at higher risk (e.g., black men, those with family histories of prostate cancer), individualize screening decisions.

  • For men aged 55 to 69, engage in shared decision making and proceed based on the man's values and preferences.

  • No “routine” screening for men older than 70 or men with life expectancy shorter than 15 years.

  • When screening, consider biennial instead of annual screening.

Comment

This guideline supplants a 2009 AUA “Best Practice Statement,” which stated that screening “. . . should be offered to healthy, well-informed men 40 years of age or older” (J Urol 2009; 182:2232). The new guideline narrows the age range for “routine” screening to 55 to 69, because that was the core age group in the European screening trial (JW Gen Med Mar 14 2012). Still, the guideline makes for some frustrating reading: Phrases such as “no routine screening” (my italics) are ambiguous, and many clinicians find difficulty in navigating the interplay between a patient's “values and preferences” and the complexity of potential benefits and harms of screening.

Many media reports publicized the new guideline as evidence that urologists are backing off from aggressive PSA screening. However, some urologists have criticized the AUA for not presenting screening more favorably. And finally, this guideline differs substantially from that of the U.S. Preventive Services Task Force, which recommends against PSA screening for all age groups (JW Gen Med Jun 7 2012).

  • Disclosures for Allan S. Brett, MD at time of publication Nothing to disclose

Citation(s):

Reader Comments (2)

David Terp

We should continue to check it on men 50-75, perhaps biennially, and younger with higher risk men.

Competing interests: None declared

David Most, PhD Other, Urology, Juno Beach, FL

After so many years of hearing "early detection, early detection", the recent anti-early detection barrage has succeeded in creating much confusion and uncertainly. Early detection does give men the best opportunity for making informed decisions. Bombarding men (and women) with anti-screening messages will likely halt the slow decline in death rates attributable to screening and early detection.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement